CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Fresenius Medical Care AG & Co KGaA - FME CFD

36.29
2.23%
Market Trading Hours* (UTC) Opens on Friday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.18
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022102 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022102%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000121 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000121%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Fresenius Medical Care AG ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 35.5
Open* 35.53
1-Year Change* -14.59%
Day's Range* 35.53 - 36.39
52 wk Range 30.16-49.62
Average Volume (10 days) 394.97K
Average Volume (3 months) 9.53M
Market Cap 10.42B
P/E Ratio 23.15
Shares Outstanding 293.41M
Revenue 19.46B
EPS 1.53
Dividend (Yield %) 3.15493
Beta 0.92
Next Earnings Date Feb 20, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 17, 2024 35.50 0.72 2.07% 34.78 35.81 34.75
Apr 16, 2024 34.87 -0.19 -0.54% 35.06 35.52 34.80
Apr 15, 2024 35.25 0.08 0.23% 35.17 35.52 34.76
Apr 12, 2024 35.44 -0.09 -0.25% 35.53 35.97 35.34
Apr 11, 2024 35.24 -0.26 -0.73% 35.50 35.88 35.08
Apr 10, 2024 35.62 0.08 0.23% 35.54 36.20 35.27
Apr 9, 2024 35.28 0.48 1.38% 34.80 35.40 34.48
Apr 8, 2024 34.85 0.29 0.84% 34.56 34.95 34.51
Apr 5, 2024 34.50 -0.15 -0.43% 34.65 34.76 34.32
Apr 4, 2024 34.92 0.24 0.69% 34.68 35.28 34.65
Apr 3, 2024 34.70 -0.11 -0.32% 34.81 34.82 34.04
Apr 2, 2024 34.86 -0.38 -1.08% 35.24 35.31 34.52
Mar 28, 2024 35.56 -0.25 -0.70% 35.81 36.00 35.35
Mar 27, 2024 35.52 0.87 2.51% 34.65 35.69 34.65
Mar 26, 2024 34.70 0.01 0.03% 34.69 34.87 34.60
Mar 25, 2024 35.00 0.56 1.63% 34.44 35.14 34.38
Mar 22, 2024 34.58 -0.18 -0.52% 34.76 35.46 34.53
Mar 21, 2024 35.11 -0.71 -1.98% 35.82 35.96 34.98
Mar 20, 2024 35.71 -0.02 -0.06% 35.73 35.92 35.40
Mar 19, 2024 35.88 1.15 3.31% 34.73 35.94 34.73

Fresenius Medical Care AG & Co KGaA Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

05:00

Country

DE

Event

Q1 2024 Fresenius Medical Care AG Earnings Release
Q1 2024 Fresenius Medical Care AG Earnings Release

Forecast

-

Previous

-

Time (UTC)

12:00

Country

DE

Event

Q1 2024 Fresenius Medical Care AG Earnings Call
Q1 2024 Fresenius Medical Care AG Earnings Call

Forecast

-

Previous

-
Thursday, May 16, 2024

Time (UTC)

08:00

Country

DE

Event

Fresenius Medical Care AG Annual Shareholders Meeting
Fresenius Medical Care AG Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, May 17, 2024

Time (UTC)

12:00

Country

DE

Event

Fresenius Medical Care AG
Fresenius Medical Care AG

Forecast

-

Previous

-
Monday, May 20, 2024

Time (UTC)

10:59

Country

DE

Event

Fresenius Medical Care AG at Barclays European Select Conference
Fresenius Medical Care AG at Barclays European Select Conference

Forecast

-

Previous

-
Tuesday, May 21, 2024

Time (UTC)

10:59

Country

DE

Event

Fresenius Medical Care AG at Berenberg European Conference
Fresenius Medical Care AG at Berenberg European Conference

Forecast

-

Previous

-
Wednesday, May 22, 2024

Time (UTC)

10:59

Country

DE

Event

Fresenius Medical Care AG at Deutsche Bank European Champions Conference
Fresenius Medical Care AG at Deutsche Bank European Champions Conference

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 19398 17618.7 17859.1 17476.6 16546.9
Revenue 19398 17618.7 17859.1 17476.6 16546.9
Cost of Revenue, Total 14087.8 12541.7 12321.6 12080.7 11392.1
Gross Profit 5310.25 5077.03 5537.44 5395.85 5154.74
Total Operating Expense 17886.3 15766.4 15554.7 15207 13509.1
Selling/General/Admin. Expenses, Total 3528.86 2996.98 3102.8 2939.13 2709.78
Research & Development 218.63 214.345 188.75 164.976 133.274
Depreciation / Amortization 9.994 6.437 5.024 3.052 0.341
Interest Expense (Income) - Net Operating 29.864 -26.024 -115.456 -73.611 -65.408
Unusual Expense (Income) 11.147 33.005 51.92 92.744 -661.043
Operating Income 1511.76 1852.29 2304.41 2269.56 3037.8
Interest Income (Expense), Net Non-Operating -292.476 -280.429 -368.019 -429.444 -301.062
Net Income Before Taxes 1219.28 1571.86 1936.39 1840.11 2736.74
Net Income After Taxes 894.325 1219.03 1435.83 1438.5 2225.66
Minority Interest -220.92 -249.72 -271.455 -238.881 -243.733
Net Income Before Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Net Income 673.405 969.308 1164.38 1199.62 1981.92
Income Available to Common Excl. Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Income Available to Common Incl. Extra. Items 673.405 969.308 1164.38 1199.62 1981.92
Diluted Net Income 673.405 969.308 1164.38 1199.62 1981.92
Diluted Weighted Average Shares 293.246 292.945 294.056 302.691 307.275
Diluted EPS Excluding Extraordinary Items 2.29638 3.30884 3.95972 3.96318 6.45
Dividends per Share - Common Stock Primary Issue 1.12 1.35 1.34 1.2 1.17
Diluted Normalized EPS 3.98317 3.79414 4.71608 4.2027 4.70044
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 4825.28 4704.22 4996.8 5096.17 4756.68
Revenue 4825.28 4704.22 4996.8 5096.17 4756.68
Cost of Revenue, Total 3628.06 3555.08 3649.28 3737.58 3410.63
Gross Profit 1197.21 1149.14 1347.52 1358.59 1346.05
Total Operating Expense 4468.65 4443.28 4644.87 4624.52 4416.17
Selling/General/Admin. Expenses, Total 775.235 782.154 954.297 989.607 969.489
Research & Development 54.756 53.332 59.237 58.452 53.334
Depreciation / Amortization 2.428 2.428 2.812 3.032 2.084
Interest Expense (Income) - Net Operating -32.101 -15.251 -19.257 -17.448 -19.367
Operating Income 356.627 260.937 351.934 471.643 340.51
Interest Income (Expense), Net Non-Operating -80.543 -82.572 -75.315 -76.485 -71.579
Net Income Before Taxes 276.084 178.365 276.619 395.158 268.931
Net Income After Taxes 194.946 133.853 193.582 282.932 206.005
Minority Interest -54.587 -47.491 -54.778 -52.832 -58.865
Net Income Before Extra. Items 140.359 86.362 138.804 230.1 147.14
Net Income 140.359 86.362 138.804 230.1 147.14
Income Available to Common Excl. Extra. Items 140.359 86.362 138.804 230.1 147.14
Income Available to Common Incl. Extra. Items 140.359 86.362 138.804 230.1 147.14
Diluted Net Income 140.359 86.362 138.804 230.1 147.14
Diluted Weighted Average Shares 293.413 293.413 293.415 293.413 293.145
Diluted EPS Excluding Extraordinary Items 0.47837 0.29434 0.47306 0.78422 0.50194
Dividends per Share - Common Stock Primary Issue 0 0 1.12 0 0
Diluted Normalized EPS 0.52934 0.52287 1.47121 0.42868 0.70576
Unusual Expense (Income) -3.819 80.353 -1.503 -146.699
Other Operating Expenses, Total 44.085 -14.811
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 8203.46 7967.24 7275.31 7165.15 7846.89
Cash and Short Term Investments 1443.77 1618.02 1243.23 1141.05 2265.14
Cash 911.015 925.134 746.851 768.706 831.885
Cash & Equivalents 362.772 556.521 334.688 239.017 1313.75
Short Term Investments 169.983 136.362 161.688 133.322 119.507
Total Receivables, Net 3882.04 3769.23 3579.29 3969.26 3765.57
Accounts Receivable - Trade, Net 3574.27 3409.06 3153.04 3421.35 3337.71
Total Inventory 2296.21 2038.01 1895.31 1663.28 1466.8
Prepaid Expenses 410.334 377.907 374.081 178.474 135.729
Other Current Assets, Total 171.093 164.07 183.398 213.086 213.646
Total Assets 35754.1 34366.6 31689 32934.7 26242.3
Property/Plant/Equipment, Total - Net 8339.81 8551.47 8186.75 8515.4 3836.01
Property/Plant/Equipment, Total - Gross 17936.7 16654.3 14830.4 14413.4 8507.4
Accumulated Depreciation, Total -9596.91 -8102.86 -6643.68 -5897.98 -4671.39
Goodwill, Net 15791.2 14361.6 12958.7 14017.3 12209.6
Intangibles, Net 1518.68 1459.39 1381.01 1426.33 681.331
Long Term Investments 773.724 786.905 761.113 696.872 649.78
Other Long Term Assets, Total 1127.27 1239.97 1126.12 1113.74 1018.66
Total Current Liabilities 6467.31 7257.63 6159.64 7007.23 6268.28
Accounts Payable 813.255 736.069 731.993 716.526 641.271
Accrued Expenses 2183.85 2225.56 2115.75 1964.24 2056.49
Notes Payable/Short Term Debt 669.013 1255.85 79.27 1171.85 1394.19
Current Port. of LT Debt/Capital Leases 1367.89 1329.54 1617.52 2086.16 1244.73
Other Current Liabilities, Total 1433.31 1710.61 1615.11 1068.46 931.597
Total Liabilities 21764.7 21667.8 20474 20976.8 14483.9
Total Long Term Debt 11175.7 10734.8 10683.2 10524.6 5045.52
Long Term Debt 7170.73 6646.95 6800.1 6458.32 5018.76
Capital Lease Obligations 4004.94 4087.8 3883.13 4066.3 26.757
Deferred Income Tax 936.475 868.452 785.886 739.702 626.521
Minority Interest 1459.73 1280.25 1116.23 1269.32 1143.55
Other Liabilities, Total 1725.47 1526.68 1728.96 1435.95 1399.99
Total Equity 13989.5 12698.8 11215.1 11957.9 11758.4
Common Stock 293.413 293.004 292.877 304.437 307.879
Additional Paid-In Capital 3372.8 2891.28 2872.63 3607.66 3873.34
Retained Earnings (Accumulated Deficit) 10711.7 10826.1 10254.9 9454.86 8831.93
Treasury Stock - Common 0 -370.502 -50.993
Other Equity, Total -388.468 -1311.64 -2205.34 -1038.55 -1203.75
Total Liabilities & Shareholders’ Equity 35754.1 34366.6 31689 32934.7 26242.3
Total Common Shares Outstanding 293.413 293.004 292.877 298.329 306.879
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 9054.21 8347.01 8561.71 8203.46 8512.67
Cash and Short Term Investments 1553.25 1361.3 1223.89 1273.79 1113.55
Cash & Equivalents 1553.25 1361.3 1223.89 1273.79 1113.55
Total Receivables, Net 3714.23 3646.05 3995.29 3714.34 3972.16
Accounts Receivable - Trade, Net 3662.14 3558.73 3905.92 3574.27 3815.37
Total Inventory 2303.9 2335.44 2328.03 2296.21 2409.68
Other Current Assets, Total 1482.82 1004.22 1014.51 919.112 1017.27
Total Assets 35634.7 34960.1 35500.5 35754.1 38406.4
Property/Plant/Equipment, Total - Net 7885.47 7930.77 8081.88 8339.81 9095.34
Goodwill, Net 15407.3 15423.3 15478.4 15791.2 17187.1
Intangibles, Net 1406.61 1400.53 1416.8 1518.68 1603.8
Long Term Investments 705.102 696.388 798.025 773.724 767.699
Other Long Term Assets, Total 1176.03 1162.16 1163.7 1127.27 1239.82
Total Current Liabilities 6619.33 6624.18 6491.84 6467.31 6357.39
Accounts Payable 753.12 720.307 822.336 813.255 828.09
Accrued Expenses 3579.34 3337.51 3322.33 3355.14 3878.43
Notes Payable/Short Term Debt 549.829 904.334 712.94 669.013 582.523
Current Port. of LT Debt/Capital Leases 1357.58 1353.19 1354.96 1367.89 790.326
Other Current Liabilities, Total 379.453 308.84 279.268 262.015 278.022
Total Liabilities 21628.1 21431.9 21672.6 21764.7 23355
Total Long Term Debt 11067.1 10808.3 11197.9 11175.7 12412.7
Long Term Debt 7264.34 6997.11 7327.59 7170.73 8068.49
Capital Lease Obligations 3802.76 3811.16 3870.32 4004.94 4344.2
Deferred Income Tax 853.787 863.968 900.165 936.475 994.803
Minority Interest 1428.01 1401.97 1399.03 1459.73 1683.96
Other Liabilities, Total 1659.91 1733.54 1683.67 1725.47 1906.18
Total Equity 14006.6 13528.2 13827.9 13989.5 15051.4
Common Stock 293.413 293.413 293.413 293.413 293.413
Additional Paid-In Capital 3378.07 3371.13 3365.09 3372.8 3360.75
Retained Earnings (Accumulated Deficit) 10759.2 10643.2 10851.4 10711.7 10478.5
Other Equity, Total -424.13 -779.544 -682.02 -388.468 918.768
Total Liabilities & Shareholders’ Equity 35634.7 34960.1 35500.5 35754.1 38406.4
Total Common Shares Outstanding 293.413 293.413 293.413 293.413 293.413
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 894.325 1219.03 1435.83 1438.5 2225.66
Cash From Operating Activities 2167.38 2489.5 4233.16 2566.95 2061.91
Cash From Operating Activities 1838.36 1623.68 1785.9 1593.16 724.847
Deferred Taxes -41.471 67.259 111.104 64.266 89.171
Non-Cash Items 126.649 232.342 215.137 304.705 -824.73
Cash Taxes Paid 334.615 345.052 301.663 387.719 358.386
Cash Interest Paid 350.681 341.629 379.994 470.223 311.971
Changes in Working Capital -650.487 -652.807 685.184 -833.68 -153.034
Cash From Investing Activities -734.725 -1196.23 -1334.94 -3285.99 -245.039
Capital Expenditures -770.336 -886.715 -1085.23 -1162.76 -1142.38
Other Investing Cash Flow Items, Total 35.611 -309.513 -249.709 -2123.22 897.34
Cash From Financing Activities -1617.36 -1024.38 -2664.03 -466.633 -681.736
Financing Cash Flow Items -123.95 -279.535 -693.531 153.387 -528.009
Total Cash Dividends Paid -395.556 -392.455 -351.17 -354.636 -324.838
Issuance (Retirement) of Stock, Net 20.153 6.511 -353.335 -583.932 10.183
Issuance (Retirement) of Debt, Net -1118.01 -358.903 -1265.99 318.548 160.928
Foreign Exchange Effects -23.162 131.228 -160.371 47.76 32.387
Net Change in Cash -207.868 400.116 73.816 -1137.91 1167.52
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 133.853 894.325 700.743 417.811 211.806
Cash From Operating Activities 142.835 2167.38 1567.72 910.11 158.697
Cash From Operating Activities 437.814 1838.36 1343.69 841.707 418.957
Deferred Taxes -22.373 -41.471 -60.08 -63.14 -9.295
Non-Cash Items 29.157 126.649 103.348 193.575 54.974
Cash Taxes Paid 33.575 334.615 233.758 197.797 44.301
Cash Interest Paid 77.255 350.681 238.716 138.032 79.484
Changes in Working Capital -435.616 -650.487 -519.981 -479.843 -517.745
Cash From Investing Activities -163.277 -734.725 -509.78 -408.988 -211.316
Capital Expenditures -146.326 -723.988 -534.505 -395.112 -198.313
Other Investing Cash Flow Items, Total -16.951 -10.737 24.725 -13.876 -13.003
Cash From Financing Activities 2.014 -1617.36 -1497.44 -994.912 -266.641
Financing Cash Flow Items 150.852 -123.95 -128.948 73.638 464.211
Issuance (Retirement) of Stock, Net 0 20.153 20.151 20.145 0.792
Issuance (Retirement) of Debt, Net -148.838 -1118.01 -993.091 -693.139 -731.644
Foreign Exchange Effects -31.469 -23.162 71.401 36.807 10.947
Net Change in Cash -49.897 -207.868 -368.103 -456.983 -308.313
Total Cash Dividends Paid -395.556 -395.556 -395.556

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Fresenius Medical Care Company profile

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Fresenius Medical Care AG & Co. KGaA revenues decreased 1% to EUR17.62B. Net income decreased 17% to EUR969M. Revenues reflect Health Care Services decrease of 2% to EUR13.88B, Health Care Products remaining flat at EUR3.74B. Net income also reflects Income from equity method investees decrease of 3% to EUR92M (income). Dividend per share increased from EUR1.34 to EUR1.35.

Equity composition

1/2006, 1-for-1 Complex capital change(Factor: 1). 3/2006, Company name changed from Fresenius Medical Care AG. 06/2007, 3-for-1 stock split.

Industry: Healthcare Facilities & Services (NEC)

Else-Kröner-Straße 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

XRP/USD

0.49 Price
-2.050% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

2,965.66 Price
+0.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,404.55 Price
+1.920% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.39

US100

17,131.40 Price
-2.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading